Mark Robinson

R&D

Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.

News

In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.